# ViCardia Therapeutics, Inc. — Form D

ViCardia Therapeutics, Inc. of SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2026-05-21. The offering totals $700K, of which $700K was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2026-05-21
- Form: D
- Accession: 0002135564-26-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $700K
- Amount sold: $700K
- Minimum investment: $10K
- Investors: 1
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-584772

## Issuer

- Name: ViCardia Therapeutics, Inc.
- CIK: 0002135564
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 530 BUSH STREET, SUITE 802, SAN FRANCISCO, CA, 94108
- Phone: 415-661-1234

## Officers, directors & promoters (1)

| Name | Role | Location |
| --- | --- | --- |
| Michael Kokesh | Related Person | San Francisco, CA |

## More

- [CIK 2135564 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2135564&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002135564-26-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.